LXRX
Lexicon Pharmaceuticals Inc
Price:  
0.75 
USD
Volume:  
4,334,663.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LXRX Relative Valuation

-1395.3%
Upside

As of 2025-06-22, the Relative Valuation of Lexicon Pharmaceuticals Inc (LXRX) is (9.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.75 USD, the upside of Lexicon Pharmaceuticals Inc based on Relative Valuation is -1395.3%.

The range of the Relative Valuation is (6.20) - (12.79) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 12.2x - 26.2x 19.2x
Forward P/E multiples 12.7x - 28.5x 20.6x
Fair Price (6.20) - (12.79) (9.71)
Upside -926.7% - -1805.4% -1395.3%
0.75 USD
Stock Price
(9.71) USD
Fair Price

LXRX Relative Valuation - Historical P/E Data

Date P/E
2025-06-13 -1.38
2025-06-12 -1.43
2025-06-11 -1.44
2025-06-10 -1.44
2025-06-09 -1.53
2025-06-06 -1.57
2025-06-05 -1.47
2025-06-04 -1.35
2025-06-03 -1.29
2025-06-02 -1.27
2025-05-30 -1.28
2025-05-29 -1.35
2025-05-28 -1.43
2025-05-27 -1.41
2025-05-23 -1.35
2025-05-22 -1.35
2025-05-21 -1.26
2025-05-20 -1.17
2025-05-19 -1.14
2025-05-16 -1.10
2025-05-15 -1.09
2025-05-14 -1.09
2025-05-13 -1.29
2025-05-12 -1.38
2025-05-09 -1.44
2025-05-08 -1.41
2025-05-07 -1.40
2025-05-06 -1.34
2025-05-05 -1.47
2025-05-02 -1.39
2025-05-01 -1.48
2025-04-30 -1.50
2025-04-29 -1.37
2025-04-28 -1.41
2025-04-25 -1.45
2025-04-24 -1.44
2025-04-23 -1.38
2025-04-22 -1.31
2025-04-21 -1.18
2025-04-17 -1.04
2025-04-16 -1.02
2025-04-15 -1.05
2025-04-14 -1.09
2025-04-11 -1.05
2025-04-10 -1.01
2025-04-09 -1.01
2025-04-08 -1.03
2025-04-07 -1.06
2025-04-04 -0.86
2025-04-03 -0.91